These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29100074)

  • 21. Depletion of SAM50 Specifically Targets BCR-ABL-Expressing Leukemic Stem and Progenitor Cells by Interfering with Mitochondrial Functions.
    Capala ME; Pruis M; Vellenga E; Schuringa JJ
    Stem Cells Dev; 2016 Mar; 25(5):427-37. PubMed ID: 26855047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells.
    Zhou LL; Zhao Y; Ringrose A; DeGeer D; Kennah E; Lin AE; Sheng G; Li XJ; Turhan A; Jiang X
    J Exp Med; 2008 Oct; 205(11):2657-71. PubMed ID: 18936234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymatically active angiogenin/ribonuclease A hybrids formed by peptide interchange.
    Harper JW; Auld DS; Riordan JF; Vallee BL
    Biochemistry; 1988 Jan; 27(1):219-26. PubMed ID: 3349027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
    Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL
    Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenin Mediates Cell-Autonomous Translational Control under Endoplasmic Reticulum Stress and Attenuates Kidney Injury.
    Mami I; Bouvier N; El Karoui K; Gallazzini M; Rabant M; Laurent-Puig P; Li S; Tharaux PL; Beaune P; Thervet E; Chevet E; Hu GF; Pallet N
    J Am Soc Nephrol; 2016 Mar; 27(3):863-76. PubMed ID: 26195817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper ion interaction with the RNase catalytic site fragment of the angiogenin protein: an experimental and theoretical investigation.
    Magrì A; Tabbì G; Breglia R; De Gioia L; Fantucci P; Bruschi M; Bonomo RP; La Mendola D
    Dalton Trans; 2017 Jul; 46(26):8524-8538. PubMed ID: 28636006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.
    Zhang B; Li L; Ho Y; Li M; Marcucci G; Tong W; Bhatia R
    J Clin Invest; 2016 Mar; 126(3):975-91. PubMed ID: 26878174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABP is necessary for stem/progenitor cell maintenance and myeloid differentiation in human hematopoiesis and chronic myeloid leukemia.
    Manukjan G; Ripperger T; Venturini L; Stadler M; Göhring G; Schambach A; Schlegelberger B; Steinemann D
    Stem Cell Res; 2016 May; 16(3):677-81. PubMed ID: 27100840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
    Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
    Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
    Chu S; McDonald T; Bhatia R
    Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo.
    Liu Y; Zhang X; An S; Wu Y; Hu G; Wu Y
    Cancer Chemother Pharmacol; 2015 Mar; 75(3):465-74. PubMed ID: 25552400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New models to investigate mechanisms of disease genesis from primitive BCR-ABL(+) hematopoietic cells.
    Eaves C; Jiang X; Eisterer W; Chalandon Y; Porada G; Zanjani E; Eaves A
    Ann N Y Acad Sci; 2003 May; 996():1-9. PubMed ID: 12799276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow mesenchymal stem cells modified by angiogenin-1 promotes tissue repair in mice with oxygen-induced retinopathy of prematurity by promoting retinal stem cell proliferation and differentiation.
    Ma QQ; Liu FY; Shi M; Sun CH; Tan Z; Chang XD; Li QP; Feng ZC
    J Cell Physiol; 2019 Nov; 234(11):21027-21038. PubMed ID: 31106420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for the autonomous promotion of cell proliferation by angiogenin.
    Hoang TT; Raines RT
    Nucleic Acids Res; 2017 Jan; 45(2):818-831. PubMed ID: 27915233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer.
    Kishimoto K; Yoshida S; Ibaragi S; Yoshioka N; Okui T; Hu GF; Sasaki A
    Oral Oncol; 2012 Nov; 48(11):1120-7. PubMed ID: 22694909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three decades of research on angiogenin: a review and perspective.
    Sheng J; Xu Z
    Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):399-410. PubMed ID: 26705141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p.
    He T; Qi F; Jia L; Wang S; Wang C; Song N; Fu Y; Li L; Luo Y
    Cancer Lett; 2015 Nov; 368(1):115-125. PubMed ID: 26272182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human angiogenin is a potent cytotoxin in the absence of ribonuclease inhibitor.
    Thomas SP; Hoang TT; Ressler VT; Raines RT
    RNA; 2018 Aug; 24(8):1018-1027. PubMed ID: 29748193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis.
    Crabtree B; Thiyagarajan N; Prior SH; Wilson P; Iyer S; Ferns T; Shapiro R; Brew K; Subramanian V; Acharya KR
    Biochemistry; 2007 Oct; 46(42):11810-8. PubMed ID: 17900154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia.
    Zong Y; Zhou S; Sorrentino BP
    Leukemia; 2005 Sep; 19(9):1590-6. PubMed ID: 16001089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.